Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 334

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 334
---
 31, 2025, the total amount outstanding under both founder notes was $957,622, including accrued interest. There are no agreements with the founders with regard to any future financing. Cash Flows DiamiR’s net cash flow from operating, investing and financing activities for the periods below were as follows:

| May 31,                                   
 2025                                      |     | For the Years Ended |          | May 31, 
 2024    |     |   |          |   |
|:------------------------------------------|:----|:--------------------|---------:|:--------|:----|:--|---------:|:--|
| Net cash (used in) provided by:           |     |                     |          |         |     |   |          |   |
| Operating activities                      |     | $                   | (313,440 | )       |     | $ | (308,914 | ) |
| Investing Activities                      |     |                     |        — |         |     |   |   (1,278 | ) |
| Financing activities                      |     |                     |  300,000 |         |     |   |  200,000 |   |
| Net decrease in cash and cash equivalents |     | $                   |  (13,440 | )       |     | $ | (110,192 | ) |

Operating Activities Net cash used in operating activities for the year ended May 31, 2025 were comparable to the prior period as lower revenue was offset by lower costs. An increase in the Company’s net loss was offset by the collection of unbilled revenue and deferred revenue. The Company’s accounts payable and accrued expense balances increased in each year. Financing Activities Net cash provided by financing activities was $300,000 for the year ended May 31, 2025, representing proceeds from a founder loan. Proceeds from founder loans amounted to $200,000 in the year ended May 31, 2024. Funding Requirements DiamiR has not completed development of any of its product candidates. DiamiR expects to continue to incur operating losses in the foreseeable future. Subject to receiving additional financing, it anticipates that its expenses will increase substantially due to continued development of CogniMIR ®,, increased development activities for pipeline projects and planned commercialization efforts. DiamiR expects that its existing cash and cash equivalents, and anticipated interest income, will not enable it to complete its development of CogniMIR ®. DiamiR’s forecast of the